So this is a new FDA approval that has no generic that could be used in the same manner? Sounds like the profit potential would be high during any pandemic or in vulnerable population areas.

Anyone want to predict the high cost of this or you think they managed to scale this drug up faster than those ADHD and glp1 drug production.